Ken Griffin ALDER BIOPHARMACEUTICALS INC Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
N/A
-633,162 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
N/A
-2,447,325 Reduced 79.45%
633,162 $0
Q2 2019

Aug 14, 2019
SELL
N/A
-16,410 Reduced 0.53%
3,080,487 $36.3 Million
Q1 2019

May 15, 2019
BUY
N/A
665,922 Added 27.39%
3,096,897 $0
Q4 2018

Feb 14, 2019
BUY
N/A
33,853 Added 1.41%
2,430,975 $0
Q3 2018

Nov 13, 2018
BUY
N/A
629,337 Added 35.6%
2,397,122 $0
Q2 2018

Aug 10, 2018
BUY
N/A
1,492,496 Added 542.16%
1,767,785 $0
Q1 2018

May 11, 2018
SELL
N/A
-2,109,652 Reduced 88.46%
275,289 $3.5 Million
Q4 2017

Feb 09, 2018
BUY
N/A
551,387 Added 30.07%
2,384,941 $27.3 Million
Q3 2017

Nov 09, 2017
BUY
N/A
1,833,554
1,833,554 $22.5 Million
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email